Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Avoid Xaar (XAR) by Steve Moore in ShareProphets
- Long Term Buy British Land Company (BLND) by Peter Stephens in The Motley Fool
- Long Term Buy Diageo (DGE) by Peter Stephens in The Motley Fool
- Long Term Buy NATWEST GROUP PLC ORD 100P (NWG) by Peter Stephens in The Motley Fool
- Long Term Buy BP (BP.) by Peter Stephens in The Motley Fool
- Long Term Buy Next (NXT) by Peter Stephens in The Motley Fool
- Sell Powerhouse Energy Group (PHE) by Tom Winnifrith in ShareProphets
- Sell Cyanconnode Holdings (CYAN) by Steve Moore in ShareProphets
- Buy Polar Capital Holdings (POLR) by Andy Ross in The Motley Fool
- Avoid Marks & Spencer Group (MKS) by Andy Ross in The Motley Fool
- Buy Blue Prism Group (PRSM) by Rupert Hargreaves in The Motley Fool
- Long Term Buy Next (NXT) by Nadia Yaqub in The Motley Fool
- Long Term Buy THG (THG) by Nadia Yaqub in The Motley Fool
- Avoid Scottish Mortgage Inv Trust (SMT) by Cliff D'Arcy in The Motley Fool
- Buy Ariana Resources (AAU) by Hot Stock Rockets in ShareProphets
- Buy Whitbread (WTB) by Chris Bailey in ShareProphets
- Buy International Consolidated Airlines Group SA (CDI) (IAG) by Royston Wild in The Motley Fool
- Buy Persimmon (PSN) by Malcolm Stacey in ShareProphets
- Avoid Tesco (TSCO) by Edward Sheldon in The Motley Fool
- Buy TI Fluid Systems (TIFS) by Royston Wild in The Motley Fool
Hikma Pharmaceuticals (HIK)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Zaven Boyrazian | – | 2021-01-07 15:05:00 07/01/2021 | – |
| – | G A Chester | – | 2021-01-04 08:35:00 04/01/2021 | – |
| – | Zaven Boyrazian | – | 2020-12-28 12:45:00 28/12/2020 | – |
| – | JP Morgan | – | 2020-11-24 11:00:00 24/11/2020 | – |
| – | Manika Premsingh | – | 2020-11-15 13:00:00 15/11/2020 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Zaven Boyrazian | – | 2021-01-07 15:05:00 07/01/2021 | – |
| – | G A Chester | – | 2021-01-04 08:35:00 04/01/2021 | – |
| – | Zaven Boyrazian | – | 2020-12-28 12:45:00 28/12/2020 | – |
| – | JP Morgan | – | 2020-11-24 11:00:00 24/11/2020 | – |
| – | Manika Premsingh | – | 2020-11-15 13:00:00 15/11/2020 | – |